Option Chain

Madrigal Pharmaceuticals Inc

MDGLNASDAQ · USD

519.06USD-2.90 (-0.56%)

239

Madrigal Pharmaceuticals Inc (MDGL) Option Chain

As of September 21, 2026, Madrigal Pharmaceuticals Inc is trading at $519.06, a -0.56% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 46.4%. IV Rank is 21%.

Tracking the MDGL option chain helps you see every strike and expiry on Madrigal Pharmaceuticals Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Madrigal Pharmaceuticals Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of MDGL options activity at a glance. Use our scanner to monitor the MDGL option chain in real time and filter for the MDGL options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For MDGL stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the MDGL option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where MDGL stock options are being actively traded and where they are not.

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745, a backup compound to resmetirom. It has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Madrigal Pharmaceuticals Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen MDGL options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of MDGL stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

IndustryBiotechnology
SectorHealthcare
IV percentile57.14% Neutral
Market cap (M$)12,059
52 weeks high-15.13%
52 weeks low32.61%
Analyst recommendationStrong Buy
1.16
Target price$678.18
30.66% above the current stock price
Dividend—
Payout ratio—
Earnings date2026-11-03
P/E—
Future P/E79.68
EPS (ttm)-12.88
EPS growth next 5 years—

As of September 21, 2026

CALLs									PUTs
Prob. OTM %	Open Interest	Volume	Extrinsic Value	Intrinsic Value	Bid	Ask	Strike	Moneyness %	Bid	Ask	Intrinsic Value	Extrinsic Value	Volume	Open Interest	Prob. OTM %
31.94	22	0	26.09	19.06	43.00	47.30	500.00	-5.93	9.00	14.70	0.00	11.85	2	165	68.06
37.99	53	0	29.94	9.06	36.00	42.00	510.00	-4.05	11.80	18.90	0.00	15.35	0	1	62.01
44.23	903	0	32.50	0.00	29.00	36.00	520.00	-2.17	15.90	23.00	0.94	18.51	10	1	55.77
50.49	6	0	27.00	0.00	24.00	30.00	530.00	-0.29	19.60	27.00	10.94	12.36	10	0	49.51
56.63	7	0	22.20	0.00	19.00	25.40	540.00	+1.60	25.60	32.00	20.94	7.86	10	76	43.37

As of September 21, 2026

Browse all Option Chain tickers

Stock Statistics

Scan the full option chain in one place